IM/SCAdult & childn ≥6 mth 0.5 mL as single dose. 1st dose should be given at least 10 days before being at risk of infection w/ yellow fever. Childn w/ insufficient response to the 1st dose or after at least 10 yr Administer 0.5 mL booster dose, as needed.
Hypersensitivity to yellow fever virus vaccine, eggs or chicken proteins. Patients who have severe allergic reaction after inj of yellow fever vaccine, immunocompromised, active HIV infection; history of thymus dysfunction; illness w/ high or moderate temp or acute illness.
Do not inject IV. Patients w/ HIV infection. Bleeding disorders (eg, haemophilia or low level of platelets) or concomitant use w/ drugs that reduce blood circulation. May cause fainting. False positive results of blood test for dengue or Japanese encephalitis may occur. Fructose intolerance. Pregnancy & lactation. Elderly >60 yr. Childn <9 mth.
Headache, asthenia, pain or discomfort at the inj site, muscle pains, fever & vomiting (in childn). Fever & vomiting (in adults), painful joints, nausea, inj site reactions (eg, redness, bruising, swelling or appearance of a hard lump).